The AI Capex Bill Comes Due
The AI Capex Bill Comes Due
The AI Capex Bill Comes Due
Sarah J. Maas is officially back. On Monday, Maas announced the titles of her two coming “A Court of Thorns and Roses” novels. “A Court of Splintered Harmony” will be released on October 27, 2026, and “A Court of Forgotten Melody” comes out January 12, 2027. The two books will form a single “ACOTAR” story…
The Reserve Bank of India on Tuesday proposed allowing mutual funds, insurance companies and pension funds to retain a standing approval to acquire higher stakes in the same bank without seeking fresh regulatory clearance each time their holdings fall below the 5% threshold. The move is aimed at easing the regulatory compliance for large institutional…
Investment bank Greenhill is hiring a former Deutsche Bank executive to lead its chemicals franchise in North America, the latest industrials banker to leave the Frankfurt-based group in the past year. Matthew Welsford is set to join the bank this month as a managing director based in Chicago, according to people familiar with the matter,…
The Internal Revenue Service has created a new Office of Conservation Easements and plans to make changes in the process for settling disputed claims for the sometimes lucrative tax breaks. Processing Content The IRS has cracked down on the tax break for landowners who set aside part of their property for conservation purposes, particularly when…
Opinions expressed by Entrepreneur contributors are their own. Key Takeaways Colleges have automated the easy work (CRM, communication) while the hardest, most labor-intensive work (transcript evaluation, fraud checks) stays manual. Enrollment growth targets are outpacing the processing capacity needed to handle more applications. Admissions leaders want AI to extend staff capacity, not replace human judgment…
This article was written by Follow Bret Jensen has been investing since the 1980s. He has been writing for Real Money Pro and Seeking Alpha since 2010. Bret specializes in high beta sectors with potentially large investor returns.Bret leads the investing group The Biotech Forum, in which he and his team offer a model portfolio…